These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11436350)

  • 1. Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases.
    Shimohata T; Onodera O; Tsuji S
    Hum Cell; 2001 Mar; 14(1):17-25. PubMed ID: 11436350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.
    Shimohata T; Nakajima T; Yamada M; Uchida C; Onodera O; Naruse S; Kimura T; Koide R; Nozaki K; Sano Y; Ishiguro H; Sakoe K; Ooshima T; Sato A; Ikeuchi T; Oyake M; Sato T; Aoyagi Y; Hozumi I; Nagatsu T; Takiyama Y; Nishizawa M; Goto J; Kanazawa I; Davidson I; Tanese N; Takahashi H; Tsuji S
    Nat Genet; 2000 Sep; 26(1):29-36. PubMed ID: 10973244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of expanded polyglutamine stretches with nuclear transcription factors leads to aberrant transcriptional regulation in polyglutamine diseases.
    Shimohata T; Onodera O; Tsuji S
    Neuropathology; 2000 Dec; 20(4):326-33. PubMed ID: 11211059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of CREB-dependent transcriptional activation by expanded polyglutamine stretches--augmentation of transcriptional activation as a potential therapeutic strategy for polyglutamine diseases.
    Shimohata M; Shimohata T; Igarashi S; Naruse S; Tsuji S
    J Neurochem; 2005 May; 93(3):654-63. PubMed ID: 15836624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dentatorubral-pallidoluysian atrophy (DRPLA)--discovery of the disease, DRPLA gene and the pathophysiology].
    Tsuji S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1287-9. PubMed ID: 11464481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1.
    Chan WM; Tsoi H; Wu CC; Wong CH; Cheng TC; Li HY; Lau KF; Shaw PC; Perrimon N; Chan HY
    Hum Mol Genet; 2011 May; 20(9):1738-50. PubMed ID: 21300695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of neurodegeneration in polyglutamine diseases].
    Tsuji S
    Rinsho Shinkeigaku; 2003 Nov; 43(11):901-2. PubMed ID: 15152498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of neurodegeneration in dentatorubral-pallidoluysian atrophy (DRPLA)].
    Tsuji S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1064-6. PubMed ID: 12235796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with activity-dependent transcriptional activation of BDNF gene depending upon the expanded polyglutamines in neurons.
    Miyashita T; Tabuchi A; Fukuchi M; Hara D; Kisukeda T; Shimohata T; Tsuji S; Tsuda M
    Biochem Biophys Res Commun; 2005 Aug; 333(4):1241-8. PubMed ID: 15979572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression.
    Lorincz MT; Detloff PJ; Albin RL; O'Shea KS
    Mol Cell Neurosci; 2004 May; 26(1):135-43. PubMed ID: 15121185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.
    Bauer PO; Nukina N
    J Neurochem; 2009 Sep; 110(6):1737-65. PubMed ID: 19650870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in understanding of clinical presentations and molecular mechanisms of triplet repeat diseases].
    Tsuji S
    Nihon Rinsho; 1999 Apr; 57(4):778-86. PubMed ID: 10222765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenic agent in Drosophila models of 'polyglutamine' diseases.
    McLeod CJ; O'Keefe LV; Richards RI
    Hum Mol Genet; 2005 Apr; 14(8):1041-8. PubMed ID: 15757976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases.
    Qi ML; Tagawa K; Enokido Y; Yoshimura N; Wada Y; Watase K; Ishiura S; Kanazawa I; Botas J; Saitoe M; Wanker EE; Okazawa H
    Nat Cell Biol; 2007 Apr; 9(4):402-14. PubMed ID: 17384639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila.
    Iijima-Ando K; Wu P; Drier EA; Iijima K; Yin JC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10261-6. PubMed ID: 16009936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
    Fu L; Gao YS; Sztul E
    Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions.
    Bates GP; Davies SW
    Mol Med Today; 1997 Nov; 3(11):508-15. PubMed ID: 9430787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein.
    Jiang H; Nucifora FC; Ross CA; DeFranco DB
    Hum Mol Genet; 2003 Jan; 12(1):1-12. PubMed ID: 12490527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.